Cetera Investment Advisers’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $866K | Buy |
13,220
+1,505
| +13% | +$98.6K | ﹤0.01% | 2507 |
|
|
2025
Q1 | $827K | Sell |
11,715
-133
| -1% | -$9.39K | ﹤0.01% | 2418 |
|
|
2024
Q4 | $779K | Sell |
11,848
-145
| -1% | -$9.53K | ﹤0.01% | 2341 |
|
|
2024
Q3 | $847K | Buy |
11,993
+686
| +6% | +$48.4K | ﹤0.01% | 2239 |
|
|
2024
Q2 | $750K | Sell |
11,307
-808
| -7% | -$53.6K | ﹤0.01% | 2281 |
|
|
2024
Q1 | $823K | Buy |
+12,115
| New | +$823K | ﹤0.01% | 2228 |
|
|
2023
Q4 | – | Sell |
-3,957
| Closed | -$233K | – | 2264 |
|
|
2023
Q3 | $233K | Sell |
3,957
-66
| -2% | -$3.89K | ﹤0.01% | 1883 |
|
|
2023
Q2 | $240K | Hold |
4,023
| – | – | ﹤0.01% | 1878 |
|
|
2023
Q1 | $235K | Buy |
4,023
+72
| +2% | +$4.21K | ﹤0.01% | 1850 |
|
|
2022
Q4 | $245K | Buy |
3,951
+300
| +8% | +$18.6K | ﹤0.01% | 1783 |
|
|
2022
Q3 | $206K | Sell |
3,651
-345
| -9% | -$19.5K | ﹤0.01% | 1488 |
|
|
2022
Q2 | $255K | Sell |
3,996
-45
| -1% | -$2.87K | ﹤0.01% | 1525 |
|
|
2022
Q1 | $262K | Sell |
4,041
-264
| -6% | -$17.1K | ﹤0.01% | 1555 |
|
|
2021
Q4 | $286K | Sell |
4,305
-21
| -0.5% | -$1.4K | ﹤0.01% | 1518 |
|
|
2021
Q3 | $264K | Sell |
4,326
-1,056
| -20% | -$64.4K | ﹤0.01% | 1519 |
|
|
2021
Q2 | $333K | Sell |
5,382
-30
| -0.6% | -$1.86K | 0.01% | 1350 |
|
|
2021
Q1 | $320K | Buy |
5,412
+93
| +2% | +$5.5K | 0.01% | 1226 |
|
|
2020
Q4 | $318K | Buy |
+5,319
| New | +$318K | 0.01% | 1206 |
|